PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis

Published:2020-03-01 Issue:2 Volume:28 Page:172-183
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

Kim Juyoung¹,Jung Kyung Hee¹,Yoo Jaeho²,Park Jung Hee¹,Yan Hong Hua¹,Fang Zhenghuan¹,Lim Joo Han¹,Kwon Seong-Ryul¹,Kim Myung Ku¹,Park Hyun-Ju²,Hong Soon-Sun¹

Affiliation:

1. Department of Medicine, College of Medicine, Inha University, Incheon 22313, Republic of Korea

2. School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea

Funder

National Research Foundation of Korea

Inha University Grant

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2020/028/BT028-02-07.pdf

Reference57 articles.

1. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

2. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors

3. Novel Phosphoinositide 3-Kinase δ,γ Inhibitor: Potent Anti-Inflammatory Effects and Joint Protection in Models of Rheumatoid Arthritis

4. PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling

5. Role of pro-inflammatory cytokines in rheumatoid arthritis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunomodulatory of interleukin-33 in rheumatoid arthritis: A systematic review;Clinical Immunology;2024-08

2. An Update on the Emerging Role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis;Current Drug Targets;2023-12

3. Omentin roles in physiology and pathophysiology: an up-to-date comprehensive review;Archives of Physiology and Biochemistry;2023-11-23

4. A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis;Journal of Pharmacy and Pharmacology;2023-09-20

5. Isoform-selective targeting of PI3K: time to consider new opportunities?;Trends in Pharmacological Sciences;2023-09